Exhibit 107

Calculation of Filing Fee Tables

S-3, 424(b)(7)

(Form Type)

Biohaven Pharmaceutical Holding Company Ltd.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee(2)

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common Shares, no par value

456(b), 457(c), 457(r)

493,254

$150.74 (1)

$74,353,107.96 (1)

0.0000927

$6,892.53

Fees Previously Paid

Carry Forward Securities

Total Offering Amounts

$74,353,107.96

Total Fees Previously Paid

Total Fee Offsets

Net Fee Due

$6,892.53

(1) Estimated solely for purposes of calculating the registration fee in accordance with Rules 457(c) and 457(r) of the Securities Act of 1933, as amended (the “Securities Act”), and based upon the average of the high and low sales price of a share of the Registrant’s common shares, as reported by the New York Stock Exchange on September 12, 2022.

(2) Calculated in accordance with Rules 456(b), 457(c) and 457(r) of the Securities Act.